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Shiga toxin-producing Escherichia coli (STEC) are considered to be a significant threat
to public health due to the severity of gastrointestinal symptoms associated with human
infection. In England STEC O157 is the most commonly detected STEC serogroup,
however, the implementation of PCR at local hospital laboratories has resulted in an
increase in the detection of non-O157 STEC. The aim of this study was to evaluate the
use of whole genome sequencing (WGS) for routine public health surveillance of non-
O157 STEC by comparing this approach to phenotypic serotyping and PCR for subtyping
the stx-encoding genes. Of the 102 isolates where phenotypic and genotypic serotyping
could be compared, 98 gave fully concordant results. The most common non-O157
STEC serogroups detected were O146 (22) and O26 (18). All but one of the 38 isolates
that could not be phenotypically serotyped (designated O unidentifiable or O rough) were
serotyped using the WGS data. Of the 73 isolates where a flagella type was available by
traditional phenotypic typing, all results matched the H-type derived from the WGS data.
Of the 140 sequenced non-O157 isolates, 52 (37.1%) harboured stx1 only, 42 (30.0%)
had stx2 only, 46 (32.9%) carried stx1 and stx2. Of these, stx subtyping PCR results were
available for 131 isolates and 121 of these had concordant results with the stx subtype
derived from the WGS data. Of the 10 discordant results, non-specific primer binding
during PCR amplification, due to the similarity of the stx2 subtype gene sequences was
the most likely cause. The results of this study showed WGS provided a reliable and
robust one-step process for characterization of STEC. Deriving the full serotype from
WGS data in real time has enabled us to report a higher level of strain discrimination while
stx subtyping provides data on the pathogenic potential of each isolate, enabling us to
predict clinical outcome of each case and to monitor the emergence of hyper-virulent
strains.
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INTRODUCTION
Shiga toxin-producing Escherichia coli (STEC) are considered to be a significant threat to public
health due to the severity of gastrointestinal symptoms associated with human infection and the risk
of cases developing Haemolytic Uraemic Syndrome (HUS; Byrne et al., 2015). STEC are zoonotic;
transmission occurs by direct contact with animals or their environment, or by consumption of
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contaminated food or water (Byrne et al., 2014). The infectious
dose is low (<10 organisms) and person-to-person spread
is common, particularly in nursery school settings and in
households with young children (Byrne et al., 2015).
In England, the current Standards for Microbiology
Investigations protocols are specific for the isolation of
non-sorbitol fermenting colonies of E. coli serogroup O157 on
cefixime tellurite sorbitol MacConkey (CT-SMAC) agar. STEC
serogroups other than O157 (non-O157 STEC) are not detected
using this method (Byrne et al., 2014). However, since 2012 the
implementation of commercial PCR assays for the detection
of STEC in faecal specimens from cases with symptoms of
gastrointestinal infection, at a twelve local hospital laboratories,
has resulted in an increase in the detection of non-O157 STEC
(Byrne et al., 2014).
Faecal specimens that are PCR positive for the Shiga Toxin
(stx) genes at the local hospital laboratories in England are sent to
the Gastrointestinal Bacterial Reference Unit (GBRU) at Public
Health England (PHE) for isolation of STEC (Jenkins et al.,
2012) and subsequent serotyping (Gross and Rowe, 1985). Recent
advances in whole genome sequencing (WGS) have led to the
development of a method for high throughput sequencing of
bacterial genomes at low cost (Joensen et al., 2014). During
2014, we evaluated the use of WGS for routine public health
surveillance of non-O157 STEC by comparing this approach to
phenotypic serotyping and PCR for subtyping the stx-encoding
genes (Persson et al., 2007).
MATERIALS AND METHODS
All 167 strains of non-O157 STEC isolated during 2014 were
phenotypically serotyped by the agglutination of antibodies
raised in rabbits to the lipopolysaccharide O antigen and to
the flagella H antigen (Gross and Rowe, 1985). Real-time PCR
targeting stx1 and stx2 and the stx subtyping PCR was performed
as previously described (Persson et al., 2007; Jenkins et al.,
2012).
Genomic DNA extracted from 140 of the 167 strains of
non-O157 STEC was fragmented and tagged for multiplexing
with Nextera XT DNA Sample Preparation Kits (Illumina) and
sequenced using the Illumina HiSeq 2500. A reference database,
SerotypeFinder, containing the gene sequences encoding the
180 O antigen groups (wzx, wzy, wzm, and wzt) and the 53
H antigens (fliC, flkA, fllA, flmA, and flnA) was constructed
and developed by Joensen et al. (2015). Using the GeneFinder
tool (Doumith unpublished), FASTQ reads were mapped to
the genes in the SerotypeFinder database using Bowtie 2
(Langmead and Salzberg, 2012) and the best match to each
of the O and H determinants was reported with metrics
including coverage, depth, mixture and homology in an
XML format for quality assessment. Only in silico predictions
of serotype that matched to a gene determinant at >80%
nucelotide identity over >80% length were accepted. Stx
subtyping was performed as described by Ashton et al. (2015).
FASTQ sequences were deposited in the National Center for
Biotechnology Information Short Read Archive under the
bioproject PRJNA248064.
RESULTS
Whole genome sequences were available for 140 of the 167
non-STEC isolates reported in 2014 (Supplementary Table).
Of these, 102 had a phenotypically derived serogroup, 25 did
not agglutinate with the antisera in the serotyping scheme
raised to the known E. coli serogroups and were designated “O
unidentifiable,” and 13 did not express the O antigen and were
designated “O rough.” Of the 102 isolates where phenotypic
and genotypic serotyping could be compared, 98 gave fully
concordant results (Supplementary Table). The most common
non-O157 STEC serogroups detected were O146 (22) and O26
(18). There were 15 strains of STEC O55, all from cases linked to
an outbreak in the South of England.
Of the four results that were not fully concordant, two
isolates serogrouped as O186 phenotypically but were designated
O123/O186 by in silico serotyping and one typed as O178
phenotypically and was designated O153/178 using WGS data.
There was one mismatch; STEC O74 was identified as STEC
O187 when the serotype was derived from the genome. The
in silico serotyping method failed to type one isolate, STEC
O146:H21, due to the short read sequences having low mapping
coverage of the O antigen encoding genes. All but one of the 38
isolates that could not be phenotypically serotyped (designated
O unidentifiable or O rough) were serotyped using the WGS
data (Supplementary Table). The most common WGS derived
serotypes that were untypable using the phenotypic approach
were O91:H14, O117:H7, and O80:H2.
There were 102 isolates that were processed for H-typing, of
which 29 were found to be non-motile and could not be typed.
Of the 73 isolates where a flagella type was available by traditional
phenotypic typing, all results matched the H-type derived from
the WGS data. All the non-motile isolates were typable using the
in silico serotyped by in silico serotyping (Supplementary Table).
Of the 140 sequenced non-O157 isolates, 52 (37.1%)
harboured stx1 only, 42 (30.0%) had stx2 only, 46 (32.9%) carried
stx1 and stx2. Of these, stx subtyping PCR results were available
for 131 isolates and 121 of these had concordant results with the
stx subtype derived from the WGS data (Supplementary Table).
The most frequently detected stx subtype profile was stx1a
only (38), most commonly associated with serotypes O103:H2
(14), O26:H11 (8), and O117:H7 (8) (Supplementary Table).
There were 14 isolates with stx1c only, including O146:H21 (5)
and O76:H19 (3). All stx1a and stx2b strains belonged to STEC
O91:H14 (9). There were 23 isolates that had stx1c and stx2b
associated with serogroups O146:H21 (9), O128:H2 (8), O113:H4
(2), and O174:H8 (2). The combination of stx1a and stx2a was
found almost exclusively in O26:H11 (7), the one exception being
an isolate of STEC O71:H2. Of the 21 isolates harbouring stx2a
only, 15 were STEC O55:H7 and two were O26:H11. Of the 10
isolates that had stx2d, three belonged to O146:H21 (and also
had stx1c), six were O80:H2 and one was O26:H11. Other rare
subtypes (one case of each) included stx2e (O8:H9) and stx2g
(O187:H28) (Supplementary Table).
There were 10 cases of HUS in 2014 (including five cases
belonging to an outbreak of STEC O55:H7), eight had STEC
harbouring stx2a, one had STEC O80:H2 carrying stx2d, and
O103:H2 stx1a was isolated from the tenth case.
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DISCUSSION
The results of this study showed WGS provided a reliable and
robust one-step process for characterisation of STEC. Previous
studies have shown an increasing number of strains of STEC
reported as “O group unidentifiable” due to antisera failing
quality control procedures, unresolvable cross reactions, lack
of expression of O antigens (designated “rough”) or novel
serogroups (Jenkins et al., 2003; Byrne et al., 2014). In this study,
all but one of the isolates that were previously phenotypically
untypable, were serotyped using data derived from the genome.
Of the 10 mismatched results identified in the comparison
between the stx subtyping PCR (Scheutz et al., 2012) and the
WGS approach (Ashton et al., 2015), all 10 had additional stx
subtypes detected by PCR that were not identified in the WGS
data (Supplementary Table). Non-specific primer binding during
PCR amplification, due to the similarity of the stx2 subtype gene
sequences was the most likely cause.
Historically, the most common stx profile of STEC O26 was
stx1a but over the last 10 years a more virulent STEC O26 variant
harbouring stx2a has emerged across Europe (Bielaszewska
et al., 2013). The enhanced strain characterisation data that
WGS provides facilitated the surveillance of emerging strains of
STEC associated with more severe disease (for example STEC
O55:H7 stx2a, STEC O26:H11 stx2a, STEC O80:H2 stx2d) and
with novel stx profiles (for example STEC O26:H11 stx2d) and
enabled us to compare data with colleagues in the field (Mariani-
Kurkdjian et al., 2014; Delannoy et al., 2015). Previous studies
have also reported an association between stx2a and severe
disease (Ethelberg et al., 2004; Byrne et al., 2014). The eae gene
was detected in 62 (44%) of the 140 non-O157 STEC isolates. All
10 isolates from the HUS cases had eae. None of the STEC strains
in this data set had aggR, previously detected in highly pathogenic
STEC variants (Boisen et al., 2015).
Prior to the implementation of WGS, due to limited resources
and time constraints, H-typing and stx subtyping of STEC were
not routinely reported by GBRU. Deriving the full serotype from
WGS data in real time has enabled us to report a higher level
of strain discrimination while stx subtyping provides data on
the pathogenic potential of each isolate, enabling us to predict
clinical outcome of each case and to monitor the emergence of
hyper-virulent strains.
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